AstraZeneca at FoG London 2027
Jan 27–28, 2027 London, UK ~8.3k attendees Website
AstraZeneca takes part in 2 sessions at FoG London 2027 in London. Its sessions cover how to pick a sequencing technology and how the human role shifts from being in the loop to being on the loop. The sequencing topic weighs short reads against long reads and newer approaches.
| Organization | FoG London 2027 Attendance |
|---|---|
AstraZeneca Cambridge, UK | |
Global biopharmaceutical company with medicines in oncology, rare disease, cardiovascular, renal, respiratory and immunology. | Panel Wed Jan 27 17:30–18:00 Choosing the Right Sequencing Technology: Short Reads, Long Reads & Beyond How researchers weigh short-read and long-read sequencing on accuracy, resolution, throughput and cost, and when to combine them. Talk Wed Jan 27 17:30–18:00 From Human IN the Loop to Human ON the Loop Why scientists should help build AI tools from the start, and why keeping them reliable needs ongoing scientific oversight. Also |
Find decision makers at AstraZeneca
Tell us what you sell and we’ll find the people at AstraZeneca most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction